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Abstract
Background: Auditory verbal hallucinations (AVHs) represent one of the most intriguing phenomena in schizophrenia,
however, brain abnormalities underlying AVHs remain unclear. The present study examined the association between
cortical thickness and AVHs in first-episode schizophrenia.
Method: High-resolution MR images were obtained in 49 first-episode schizophrenia (FES) patients and 50
well-matched healthy controls (HCs). Among the FES patients, 18 suffered persistent AVHs (“auditory hallucination” AH
group), and 31 never experienced AVHs (“no hallucination” NH group). The severity of AVHs was rated by the Auditory
Hallucinations Rating Scale (AHRS). Cortical thickness differences among the three groups and their association with
AVHs severity were examined.
Results: Compared to both HCs and NH patients, AH patients showed lower cortical thickness in the right Heschl’s
gyrus. The degree of reduction in the cortical thickness was correlated with AVH severity in the AH patients.
Conclusions: Abnormalities of cortical thickness in the Heschl’s gyrus may be a physiological factor underlying auditory
verbal hallucinations in schizophrenia.
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Background
Schizophrenia is one of the most debilitating mental
illnesses [1], characterized by positive symptoms, negative
symptoms and cognitive deficits. As a core positive symp-
tom, auditory verbal hallucinations (AVHs) is an import-
ant diagnostic criterion for schizophrenia [2], which has
been shown to be closely related to schizophrenia patients’
long-term social functioning and quality of life [3].
Previous neuroimaging studies have revealed widespread
morphological abnormalities associated with AVHs, such
as gray matter loss in the frontal [4, 5], insular [6], and
anterior/posterior cingulate [7, 8] cortices. The most
extensively focused brain region in the investigation of
AVHs is the temporal lobe, in particular the primary audi-
tory cortex (PAC, also known as Heschl’s gyrus), and the
secondary auditory cortex [9]. Both are known to be cru-
cial for auditory perception and comprehension [10]. Sev-
eral lines of evidence have shown that schizophrenia
patients with AVHs present reduced gray matter volumes
in the superior and transverse temporal gyri [11–13]. Fur-
thermore, a recent meta-analysis of voxel-based morph-
ometry (VBM) studies included a large sample totaling
438 patients (307 with AVHs) and confirmed a significant
correlation between the extent of gray matter loss in the
Heschl’s gyrus (HG) and the severity of AVHs [14]. Inter-
estingly, by applying a manual segmentation method, an-
other study found that hallucinating patients exhibited
increased volume in the HG [15]. Yet another study found
that schizophrenia patients with AVHs had increased
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volumes of temporal gray and white matter compared pa-
tients without AVHs [4]. The inconsistent findings may be
accounted for by differences in methodology [14], hallu-
cination history [16], symptom diversity [17], substance
abuse [18], illness course [19, 20], and antipsychotic medi-
cation use [21]. Thus, controlling potentially confounding
factors listed above may help provide more reliable evi-
dence on the alternations in brain structures underpinning
AVHs.
In the present study, we recruited two groups of first-
episode schizophrenia patients, who were carefully matched
for socio-demographic variables, illness course, medication
dose, and symptom severity (except for the AVHs). The
auditory hallucination (AH) group included patient with
current and persistent AVHs. Patients without current
hallucinations or with only occasional hallucinations
based on the Scale for Assessment of Positive Symptoms
(SAPS) were excluded. In the no hallucination (NH)
group, patients with any AVH history were excluded.
(For detailed inclusion and exclusion criteria, please see
Methods). Furthermore, a group of healthy controls
(HCs) was also recruited, matching the patients in age,
sex and years of education.
By applying a novel surface-based analysis approach to
the matched schizophrenia patient samples, we aimed at
characterizing the cortical thickness in the first-episode
schizophrenia patients with and without AVHs. We ex-
pected patients with AVHs to show altered cortical
thickness correlating with their AVH severity.
Methods
Study subjects
Forty-nine right-handed first-episode schizophrenia (FES)
patients who were diagnosed with schizophrenia within
the past 18 months with no previous episodes of psychosis
as per Diagnostic and Statistical Manual for Mental
Disorders Fourth Edition (DSM-IV), determined by the
Structured Clinical Interview for DSM-IV Axis I Disorders,
Patient Edition (SCID-I/P) [22], were recruited from an in-
patient unit at the Second Xiangya Hospital of Central
South University, Changsha. Inclusion criteria for both pa-
tients and healthy controls were similar: (1) age between 18
and 45 years old; (2) Han Chinese; and (3) sufficient under-
standing and expressive capacity with ≥9 years of education.
Exclusion criteria for participants were: (1) moderate to se-
vere learning disability; (2) a history of substance abuse; (3)
a history of brain trauma or neurological disease; (4) left-
handedness; and (5) previous electroconvulsive therapy and
any other contraindications to MRI. Diagnosis of schizo-
phrenia and the symptom ratings were determined by the
consensus of two experienced psychiatrists (Z.L. and H.L.).
The hallucination history was determined based on the
SCID-I/P hallucinations items. Of the patients with
first-episode schizophrenia, 18 suffered persistent AVHs
and were classified as the auditory verbal hallucinations
group (AH). In particular, patients were assigned to the
AH group if they scored >2 on item 2 or 3 of the SAPS
and patients with occasional hallucinations were excluded
(hallucinations score = 2). The other 31 patients with first-
episode schizophrenia had never experienced auditory
verbal hallucinations (no hallucinations group, NH).
Fifty right-handed healthy controls (HCs) were re-
cruited from the city of Changsha through poster adver-
tisements and screened. HCs were evaluated using the
SCID-Non-Patient Edition to confirm the lifetime ab-
sence of psychiatric and neurological illnesses [23]. HCs
who met the DSM-IV criteria for an Axis-I psychiatric
disorder were excluded. Additionally, healthy subjects
were interviewed to confirm that there was no history of
psychiatric illnesses among their first-degree relatives.
The Ethics Committee at Second Xiangya Hospital of
Central South University reviewed and approved the
study. All participants received a description of the ex-
perimental procedures and gave written informed con-
sent to participate in the study.
Participants’ IQ was estimated using the information
subscale and digit-symbol coding subscale of the Wechsler
Adult Intelligence Scale (WAIS)-Chinese version [24]. In
subjects with schizophrenia, positive and negative symp-
toms within 1 month prior to the study were assessed
using the Scale for Assessment of Positive Symptoms
(SAPS) [25] and the Scale for the Assessment of Negative
Symptoms (SANS) [26], respectively. AVH severity was
evaluated using the Auditory Hallucinations Rating Scale
(AHRS). This questionnaire assesses multiple characteris-
tics of AVHs, such as the frequency of occurrence, length
of episodes, loudness of the voices, and influence and dis-
comfort of AVHs as experienced by the patient [27]. Dos-
age of antipsychotic medication equivalent to 100 mg/day
of chlorpromazine (CPZ) was also calculated [28]. Hand-
edness was ascertained using the Annett Hand Preference
Questionnaire [29].
To minimize the effects of chronicity of illness and
neuroleptic medications on brain structure, this study
preferentially recruited patients who were just beginning
treatment with antipsychotic medication for the first
time and matched the medication dose between the two
patient groups. Current and previous antipsychotic regi-
mens (medication and duration of use) were recorded.
In the patient groups, two patients (4 %) never received
antipsychotic treatment, 43 patients had been on anti-
psychotic treatment for less than 4 weeks and four patients
had been treated for more than 4 weeks. One patient (2 %)
was receiving first-generation antipsychotics (FGAs)
monotherapy (sulpiride, 1 case); 41 patients (84 %) were
receiving second-generation antipsychotics (SGAs) mono-
therapy (clozapine, 1 case; risperidone, 19 cases; quetia-
pine, 2 cases; olanzapine, 15 cases; aripiprazole, 1 case;
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ziprasidone, 3 cases) and five patients (10 %) were receiv-
ing combination antipsychotic therapy (combining an
SGA and an SGA). Mean current treatment duration was
11.92 (SD = 13.52) days and mean lifetime exposure to an-
tipsychotics was 13.06 (SD = 14.95) days among the 49
patients.
Magnetic resonance imaging acquisition
High-resolution T1-weighted images were acquired
using T1-weighted 3D turbo field echo (T1W-3D-TFE)
on a 3.0-Tesla Philips Achieva MRI scanner (Philips,
The Netherlands) with the following parameters: repeti-
tion time = 7.5 ms, echo time = 3.7 ms, flip angle = 8°,
field of view = 240 × 240 mm2, acquisition matrix =
256 × 200, slice thickness = 1 mm, gap = 0, number of
slices = 180. Foam pads and earplugs were used to
minimize head motion and scanner noise. All scans were
inspected for motion artifacts. The absence of gross
pathological findings was confirmed by a neuroradiolo-
gist. All patients and controls were examined during the
same study period and there was no scanner upgrade
during this time.
Cortical thickness measurement and cortical parcellation
Images were processed and cortical thickness was mea-
sured using the longitudinal stream in FreeSurfer version
5.2.0 (http://surfer.nmr.mgh.harvard.edu/fswiki/recon-all/),
which has been validated in previous research [30]. All
the processing steps, including motion correction, skull
stripping, registration to Talairach space, intensity
normalization, segmentation of the white matter and gray
matter, tessellation of the gray-white boundary, automatic
topology correction and surface deformation, were com-
pleted using the fully automated pipeline without any
manual intervention. Cortical thickness was calculated as
the average of the closet distance from the white matter to
the vertex and the closet distance from the vertex to the
white matter [31]. The cortex of each hemisphere was
automatically parcellated into 34 regions (based on [32],
available from http://surfer.nmr.mgh.harvard.edu/fswiki/
CorticalParcellation), subdividing the human cerebral cor-
tex into standard gyral neuroanatomical regions. This
highly reliable parcellation method has been adopted in a
line of previous studies [33, 34]. The average cortical
thickness of each region from both FES patients and
HCs were extracted. All results of cortical parcellations
were examined by both visual inspection and FreeSur-
fer QA Tools (available from http://www.freesurfer.net/
fswiki/QATools).
Statistics
Statistical analysis was performed with Statistical Package
for Social Sciences, version 17.0 (SPSS Inc., Chicago,
Illinois). Differences in age and educational levels
among the three groups were assessed using Analyses
of Variance (ANOVA). Gender differences were com-
pared using the chi-squared test. The average cortical
thickness in the 34 regions of each hemisphere was ex-
tracted and entered into SPSS software using a general
linear model and compared among the patient groups
and healthy controls, with age and sex serving as covar-
iates. Significance was set to p < .05, corrected for mul-
tiple comparisons using Least Significant Difference
(LSD).
Pearson correlation analysis was performed on the
average cortical thickness in regions with altered thick-
ness and the AHRS scores, and the total score of the
SAPS and SANS to examine potential associations be-
tween anatomical deficits and clinical symptoms. Fur-
thermore, we used Pearson correlation to quantify the
relationship between the duration of illness and the al-
terations in cortical thickness. P < .05 was considered
significant. Additionally, given that the CPZ equivalent
of current medication dose did not follow a normal dis-
tribution, Spearman's rank correlation analysis between
cortical thickness and medication dose was performed.
Results
Demographic and clinical characteristics
Demographic and clinical characteristics of the groups
are shown in Table 1. There were no significant differ-
ences among the groups regarding age, sex, and years of
education. No difference emerged with respect to the
duration of illness or medication dosage between the
AH and NH patient groups. Relative to the NH patients,
the AH patients scored significantly higher on total
SAPS score, but not for total SAPS score minus halluci-
nations subscales or total SANS score. In addition, there
was no significant difference between the two patient
groups in any of the sub-scores of SANS or SAPS except
for hallucinations (see Table 1).
Alterations in patient cortical thickness
Group ANCOVA analysis demonstrated that only the
right transverse temporal cortex (Heschl’s gyrus) showed
significant difference in cortical thickness among the
three groups (F = 6.06 p < .05; see Table 2 and Additional
file 1: Table S1). Post-hoc comparisons showed that the
right HG cortical thickness was significantly reduced in
the AH patients compared to that of the NH patients as
well as the HCs (p < .05, corrected for multiple compari-
sons with LSD; see Table 2, Fig. 1)
Correlation between alterations in cortical thickness and
clinical symptoms severity
In the AH group, the average cortical thickness of the
region with reduced cortical thickness (i.e., right HG)
negatively related to the severity of AVHs, as assessed by
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Table 1 Demographic and clinical characteristics of participantsa
AH NH HC Chi-Square Analysis/t tests
(n = 18) (n = 31) (n = 50) F/χ2/t p Post Hoc
Demographics
Age, yearsb 24.11(6.27) 24.29(5.92) 24.98(6.60) F = .18 .835
Sex,n(% male) 12(66.67 %) 17(54.80 %) 25(50.00 %) χ2 = 1.48 .479
Education, yearsc 12.42(2.92) 12.50(2.22) 13.2(2.16) F = 1.22 .299
Duration of illness,monthsd 6.33(4.78) 7.09(4.48) t = −.56 .579
WAIS-Information 17.89(6.07) 16.31 (4.42) 20.22(4.50) F = −3.32 .002* NH < HC




Global rating of Hallucinations 2.78(1.93) .45(1.12) t = 5.36 <.001*
Global rating of Delusions 2.27(1.45) 2.81(1.80) t = −1.06 .293
Global rating of BizarreBehaviour .56(1.20) .87(1.15) t = −.91 .366
Global rating of Positive Formal Thought Disorder .83(1.25) .68(1.17) t = .44 .662
Total 27.78(14.65) 16.67(11.52) t = 2.94 .005*
Total – Hallucinations 14.89(10.82) 15.58(11.25) t = −.21 0.834
SANS
Global Rating of Affective Flattening 1.06(1.21) 1.35(1.50) t = −.72 .474
Global Rating of Alogia 0.83(1.20) 1.26(1.44) t = −1.06 .296
Global Rating of Avolition - Apathy 1.28(1.23) 1.68(1.70) t = −.87 .388
Global Rating of Anhedonia- Asociality 1.67(1.33) 2.42(1.59) t = −1.70 .097
Global Rating of Attention 0.83(0.92) 1.10(1.40) t = −.71 .480
Total 21.44(19.92) 30.12(25.44) t = −1.24 .220
Chlorpromazine equivalents (mg) 189.35(62.09) 250.53(201.54) t = −1.25 .218
*p < .05
HC healthy controls, AH hallucinating patients with schizophrenia, NH non-hallucinating patients with schizophrenia, Total-Hallucinations total SAPS score minus
hallucinations subscales score
AHRS Auditory Hallucinations Rating Scale, SAPS Scale for the Assessment of Positive Symptoms, SANS Scale for the Assessment of Negative Symptoms, WASI
Wechsler Abbreviated Scale of Intelligence
aMean and SD are reported unless otherwise specified. Analyses of demographics and clinical data wereperformed in SPSS (http://www.spss.com). All tests
were two-tailed
bAge was defined as age at the time of magnetic resonance imaging scanning
cYears of education refers to the total number of years of completed education as reported by the participant
dDuration of illness was defined as number of years between age at onset and age at MRI scanning
Table 2 Cortical thickness of schizophrenia patients and healthy controls in right Heschl’s gyrus
Cortical thickness(mm) ANCOVA Pairwise comparisonsa
Mean SD F P values Mean difference P values
AH 2.99 .25 AH < NH -.161 .021*
NH 3.16 .22 6.06 .003** NH < HC .062 .246
HC 3.21 .27 AH < HC -.223 .001*
*p < .05, **p < .01
HC healthy controls, AH hallucinating patients with schizophrenia, NH non-hallucinating patients with schizophrenia
aAdjustment for multiple comparisons: Least Significant Difference
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AHRS scores, but not with SAPS or SANS (see Fig. 1).
Greater reduction in the cortical thickness was observed
in patients with more severe AVHs. No significant cor-
relation was observed between the cortical thickness in
the region with altered thickness and the duration of ill-
ness (r = −.22 p > .05), or the medication dosage in the
patient groups (r = .14, p > .05).
Discussion
In line with our hypothesis, we found that reduced cortical
thickness in Heschl’s gyrus was significantly related to
auditory hallucinations in FES patients. One advantage of
the present study, which specifically isolated patients with
current and persistent auditory hallucinations and com-
pared them with matched non-hallucinating patients and
healthy controls, is phenotypic homogeneity to explore
the neural correlates of hallucinations. Notably, our pa-
tient groups differed only in terms of AVH symptomatol-
ogy, minimizing the confounding effect of other clinical
characteristics.
Several advantages of this study, particularly on the
controlling confounding factors, are of strong interest
for identifying the specific anatomical deficits associated
with verbal hallucinations. First, excessive cortex thinning
over time in the frontal and temporal areas has been dem-
onstrated in schizophrenia and the changes can progresses
across the entire course of the illness [35]. We recruited
patients with first-episode schizophrenia with relatively
short illness duration to minimize confounding effects of
the chronic illness course on the neural substrate of hallu-
cination. Second, association between psychotic symptoms
and different deficits in cortical thickness has been ob-
served [36]. Moreover, it has been indicated that anti-
psychotic drugs affect the regional cerebral volume,
particularly in the frontal lobes [37, 38] and caudate
nucleus [39]. Therefore, we matched the symptoms se-
verity (other than hallucinations) and medication dos-
age between the two patient groups, further facilitating
the identification of specific neuro-substrate of halluci-
nations. Finally, we used the surface-based cortical
thickness approach, which can acquire data at the sub-
Fig. 1 Cortical thickness analysis among patients and healthy controls groups. a Significant differences among groups were identified using ANCOVA
with age and sex as covariates (* p < .05, corrected for multiple comparisons with LSD). The right Heschl’s gyrus (labeled in green) showed significant
difference in cortical thickness among three groups. (AH < NH, HC, AH = Hallucinating patients with schizophrenia, NH = Non-hallucinating patients
with schizophrenia, HC = Healthy controls. Error bars represent SDs). b The cortical thickness of right Heschl’s gyrus was negatively correlated with the
severity of auditory verbal hallucinations, as assessed by AHRS scores
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voxel resolution [40], reflecting the size, density, and ar-
rangement of neurons, glial cells, and synaptic spines [41].
Given that surface-based methods are designed to remove
individual variability in local cortical folding [31], the cor-
tical thickness might elucidate the exact nature of potential
structural alterations in schizophrenia.
The Heschl’s gyrus belongs to the primary auditory
cortex [42], which is surrounded by the secondary audi-
tory processing areas on the superior temporal gyrus
(STG). Our findings are consistent with a recent meta-
analysis of voxel-based morphometry study [14], which
revealed that the severity of AVHs was significantly associ-
ated with gray matter volume (GMV) reductions in bi-
lateral HG and STGs. HG structural abnormality has
been reported to relate with the severity of auditory
hallucinations [13], which is also replicated in our
study. In adolescent schizophrenia patients [43], gray
and white matter volume reduction in the HG has been
observed. Furthermore, cortical thinning in the HG
was reported in both high-risk neonates and adults
with schizophrenia [34, 44], suggesting that the
HG structural abnormalities may relate to genetic
predispositions.
Previous studies also reported structural abnormalities
in other brain regions, such as frontal [4, 5], temporal
[9] and insular cortex [6], whereas we did not observe
any difference in cortical thickness in these areas. Such
contradictory findings may be attributed to differences
of methodology and schizophrenia heterogeneity. First,
in contrast to our surface-based morphometry analysis,
most previous studies applied the voxel-based morph-
ometry (VBM) approach. The VBM approach mainly fo-
cuses on the structrual changes in the gray matter
volume or density, not cortical thickness. To the best of
our acknowledge, there has been only one previously
published study assessing cortical thickness in a rela-
tively small sample of 10 chronically hallucinating
schizophrenic patients, which found cortical thickness
increase in the parahippocampal gyrus and reduction in
the frontal and temporal cortex [45]. Schizophrenia is a
very heterogeneous mental disorder. Patients present
with a variety of clinical symptoms and durations of ill-
ness. Different from that study, all patients in our study
were in their first-episode (mean duration of illness
6.8 months). Evidence has demonstrated that schizo-
phrenia patients show cortex thinning over time across
the entire course of illness [35], suggesting that the
chronicity of the illness might be an important contribu-
tor to cortical thinning. Moreover, in the present study,
we did not observe significant thickness reduction in the
left HG. This finding concurs with previous studies dem-
onstrating that in the primary auditory cortex, the mor-
phometric changes appeared to be more consistent on
the right than the left in schizophrenia patients [46, 47].
Although the underlying neuropathology of the HG
gray matter reduction is not clear, postmortem studies
have suggested that cortical thinning may reflect a loss
of neuropil or altered pruning [48, 49]. Based on the
knowledge of previous studies and our results, the ana-
tomical deficits in the primary auditory cortex may rep-
resent a core pathology of AVHs during the early course
of schizophrenia.
This study has some limitations. First, the FES patients
included in the study were not completely treatment-
naïve; most of them had received a relatively short
course of antipsychotic medications. Studies showed that
long term antipsychotic medication has a significant im-
pact on brain morphology [50]. However, the two patient
groups here did not differ in terms of medication dosage
or duration. In addition, when we further controlled for
medication effects by performing correlation analysis
with CPZ-equivalents in patient groups, and there was
no significant correlation between CPZ-equivalent and
cortical thickness. Second, our analysis method only
allowed inference on cortical thickness alterations. Due
to the limitations associated with the MRI structural
measurements, the effects of vascularization and tissue
fluid levels cannot be excluded. Third, although the total
FES group is reasonably large, the power of the study
might be limited by dividing patients into subgroups
with and without AVHs. Given the cross-sectional na-
ture of this study, we cannot exclude a potential impact
of schizophrenia heterogeneity on our findings and fu-
ture longitudinal studies are warranted to better under-
stand the developmental context of these structural
alterations in patients with auditory hallucinations.
Conclusion
In conclusion, the present study demonstrated that first-
episode schizophrenia patients with AVHs exhibit re-
duced cortical thickness in the right HG that was as-
sociated with severity of auditory hallucinations. This
finding suggests that anatomical deficits in primary
auditory cortex gyrus may modulate the pathogenesis
of auditory verbal hallucinations in the early stage of
schizophrenia.
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